SA
Log In
ABT
OverviewIntelligenceChart

Analyst Sentiment

Analysts lean bullish — 91% recommend buying.

Consensus Rating
Buy
22 analysts·High coverage
91%
Rating Distribution
Strong Buy
00%
Buy
2091%
Hold
29%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 36% higher.

Bear Case
$115.00
+19%
Consensus
$131.46
+36%
Bull Case
$152.00
+57%
Price Range22 analysts
Low
Consensus
High
$115.00
$152.00
Current Target
Current Price
$96.83
Upside to Target
$34.63

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+8.87%
EPS+10.58%
FY2028
Rev+7.00%
EPS+11.30%
FY2029
Rev+5.96%
EPS+11.50%

Earnings Surprises

Recent Analyst Actions

Apr 17, 2026UBS
Abbott price target lowered to $115 from $132 at Oppenheimer
Target:$115.00
+20.5%from $95.46
Apr 17, 2026Piper Sandler
Abbott price target lowered to $115 from $135 at Piper Sandler
Target:$115.00
+20.5%from $95.46
Apr 17, 2026Stifel Nicolaus
Abbott price target lowered to $120 from $145 at Stifel
Target:$120.00
+25.7%from $95.46
Mar 13, 2026UBS
UBS Reiterates Buy Rating on Abbott Labs (ABT) on DD Medical Device Growth Sustainability
Target:$158.00
+45.7%from $108.42
Mar 13, 2026New Street
Abbott Labs (ABT) Reiterated at Buy by Benchmark After FreeDM Trial Results
Target:$145.00
+34.1%from $108.14
Feb 2, 2026Barclays
Abbott price target lowered to $142 from $169 at Barclays
Target:$142.00
+29.9%from $109.30
Jan 29, 2026Loop Capital Markets
Freedom Capital Markets Upgrades Abbott Labs (ABT) to Buy
Target:$120.00
+13.1%from $106.09
Jan 23, 2026Evercore ISI
Abbott price target lowered to $138 from $144 at Evercore ISI
Target:$138.00
+27.1%from $108.61
Jan 23, 2026UBS
Abbott price target lowered to $132 from $140 at Oppenheimer
Target:$132.00
+21.5%from $108.60
Jan 23, 2026Mizuho Securities
Abbott price target lowered to $125 from $140 at Mizuho
Target:$125.00
+15.1%from $108.60
Jan 23, 2026Piper Sandler
Abbott price target lowered to $135 from $150 at Piper Sandler
Target:$135.00
+24.3%from $108.60
Jan 23, 2026Bernstein
Abbott price target lowered to $125 from $154 at Bernstein
Target:$125.00
+15.1%from $108.60
Jan 23, 2026Wells Fargo
Abbott price target lowered to $122 from $146 at Wells Fargo
Target:$122.00
+12.3%from $108.60
Jan 9, 2026Bernstein
Abbott price target raised to $154 from $150 at Bernstein
Target:$154.00
+22.0%from $126.18
Jan 9, 2026Goldman Sachs
Abbott price target lowered to $152 from $157 at Goldman Sachs
Target:$152.00
+20.5%from $126.18
Jan 5, 2026Evercore ISI
Abbott price target raised to $144 from $142 at Evercore ISI
Target:$144.00
+16.2%from $123.97
Jan 5, 2026Barclays
Abbott price target raised to $169 from $162 at Barclays
Target:$169.00
+36.1%from $124.19
Dec 22, 2025BTIG
BTIG Reiterates Buy Rating on Abbott Labs (ABT)
Target:$145.00
+14.9%from $126.24
Nov 21, 2025Tigress Financial
Benchmark Reiterates Buy Rating on Abbott Labs (ABT) Following Deal to Acquire Exact Sciences (EXAS)
Target:$145.00
+13.2%from $128.13
Oct 17, 2025Barclays
Abbott price target raised to $162 from $159 at Barclays
Target:$162.00
+26.9%from $127.63
Oct 16, 2025Wells Fargo
Abbott price target raised to $146 from $142 at Wells Fargo
Target:$146.00
+12.8%from $129.45
Oct 1, 2025Goldman Sachs
Abbott added to US Conviction List at Goldman Sachs
Target:$157.00
+17.2%from $133.94
Jul 15, 2025RBC Capital
Abbott price target raised to $147 from $145 at RBC Capital
Target:$147.00
+11.8%from $131.49
Apr 15, 2025RBC Capital
Abbott price target raised to $140 from $135 at RBC Capital
Target:$140.00
+10.9%from $126.22
Jan 8, 2025Bernstein
Abbott price target lowered to $135 from $138 at Bernstein
Target:$135.00
+18.2%from $114.25

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance